Your browser is no longer supported. Please, upgrade your browser.
ACRX AcelRx Pharmaceuticals, Inc. daily Stock Chart
AcelRx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own1.30% Shs Outstand69.28M Perf Week-12.59%
Market Cap259.80M Forward P/E- EPS next Y-0.84 Insider Trans3.06% Shs Float50.89M Perf Month1.35%
Income-10.90M PEG- EPS next Q-0.21 Inst Own10.00% Short Float7.66% Perf Quarter31.58%
Sales3.40M P/S76.41 EPS this Y61.00% Inst Trans1.43% Short Ratio1.76 Perf Half Y63.04%
Book/sh-0.94 P/B- EPS next Y0.00% ROA-62.40% Target Price7.80 Perf Year114.29%
Cash/sh0.72 P/C5.19 EPS next 5Y- ROE110.70% 52W Range1.65 - 5.03 Perf YTD85.19%
Dividend- P/FCF- EPS past 5Y24.40% ROI-5.90% 52W High-25.45% Beta2.17
Dividend %- Quick Ratio4.00 Sales past 5Y27.30% Gross Margin-43.30% 52W Low127.27% ATR0.50
Employees43 Current Ratio4.00 Sales Q/Q-70.40% Oper. Margin- RSI (14)52.11 Volatility13.10% 17.18%
OptionableYes Debt/Eq- EPS Q/Q29.30% Profit Margin- Rel Volume0.84 Prev Close3.63
ShortableYes LT Debt/Eq- EarningsNov 08 AMC Payout- Avg Volume2.22M Price3.75
Recom2.00 SMA200.54% SMA5010.26% SMA20034.27% Volume1,857,790 Change3.31%
Oct-13-17Reiterated RBC Capital Mkts Outperform $6 → $5
Oct-13-17Downgrade Jefferies Buy → Hold
Jul-14-17Resumed Jefferies Buy $7
Sep-15-16Reiterated ROTH Capital Buy $11.25 → $15
Aug-05-16Downgrade Stifel Buy → Hold
Oct-30-15Upgrade Jefferies Hold → Buy
Oct-05-15Reiterated ROTH Capital Buy $8.50 → $10.50
Sep-02-15Initiated H.C. Wainwright Buy $8.50
Jul-10-15Resumed ROTH Capital Buy $7.50
May-06-15Reiterated Mizuho Neutral $5.50 → $3
May-05-15Reiterated RBC Capital Mkts Outperform $8 → $7
Mar-10-15Reiterated RBC Capital Mkts Outperform $12 → $8
Mar-09-15Downgrade Mizuho Buy → Neutral $14 → $5.59
Feb-26-15Upgrade Mizuho Neutral → Buy $6 → $14
Nov-06-14Downgrade Mizuho Buy → Neutral $15 → $6
Sep-26-14Downgrade ROTH Capital Buy → Neutral
Jul-28-14Reiterated RBC Capital Mkts Outperform $15 → $12
Jul-28-14Reiterated Mizuho Buy $20 → $15
Jul-28-14Downgrade Canaccord Genuity Buy → Hold
Apr-17-14Initiated Canaccord Genuity Buy $16
Oct-22-18 07:05AM  As powerful new opioid nears FDA approval, critics ask if U.S. is stoking its drug crisis MarketWatch
Oct-19-18 03:15PM  AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting PR Newswire -12.53%
10:02AM  Controversy builds over potent new opioid medication as U.S. senator calls on FDA to reject the drug MarketWatch
Oct-17-18 08:15AM  Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.29%
Oct-16-18 04:33PM  10 Hottest Stocks From October 16, 2018 Benzinga -7.46%
06:33AM  3 Biotechs Awaiting FDA Approval Decisions Motley Fool
Oct-15-18 04:01PM  DSUVIA Efficacy and Safety Data to be Presented at the American Society of Anesthesiologists (ASA) Annual Conference PR Newswire +7.79%
12:37PM  Stock Market News Daily Roundup October 15 Market Exclusive
12:11PM  Why AcelRx Pharmaceuticals Inc. Is Jumping Today Motley Fool
11:38AM  AcelRx's Dsuvia Gets FDA Committee Approval, Shares Rally Zacks
Oct-12-18 04:15PM  FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute Pain PR Newswire
07:10AM  AcelRx Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review DSUVIA New Drug Application PR Newswire
Oct-11-18 08:00AM  Todays Research Reports on Stocks to Watch: Neovasc and AcelRx Pharmaceuticals ACCESSWIRE +10.71%
06:30AM  AcelRx Pharmaceuticals Inc. Is Soaring -- Should You Be Buying? Motley Fool
Oct-10-18 04:26PM  Why Analysts See Solid Upside Potential for Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX), and AcelRx (ACRX) SmarterAnalyst +35.66%
01:23PM  AcelRx shares surge after FDA staff says opioid safe Reuters
12:32PM  AcelRx Shares React Positively To FDA Committee Briefing On Painkiller Candidate Dsuvia Benzinga
12:20PM  FDA staff says AcelRx opioid painkiller safe and effective Reuters
Oct-08-18 07:30AM  The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs Benzinga
Sep-25-18 04:05PM  AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October PR Newswire -9.78%
08:00AM  Todays Research Reports on Stocks to Watch: Amarin Corporation and AcelRx Pharmaceuticals ACCESSWIRE
Sep-24-18 06:12PM  Here's Why AcelRx Pharmaceuticals, Inc. Jumped 16.5% on Monday Motley Fool +16.46%
Sep-11-18 07:00AM  AcelRx Announces Date of FDA Advisory Committee Meeting for DSUVIA PR Newswire
Sep-05-18 08:54AM  Are Options Traders Betting on a Big Move in AcelRx Pharmaceuticals (ACRX) Stock? Zacks
Aug-23-18 04:05PM  AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September PR Newswire
Aug-22-18 03:50PM  Edited Transcript of ACRX earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
07:50AM  New Research: Key Drivers of Growth for OncoSec Medical, AcelRx Pharmaceuticals, Cameco, Prestige Brand, Berry Global Group, and A-Mark Precious Metals Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Aug-20-18 07:00AM  AcelRx Pharmaceuticals to Present at the 2018 Military Health System Research Symposium PR Newswire
Aug-16-18 11:19AM  AcelRX Shares Should More Than Double On Painkiller Assets, Landenburg Says In Bullish Initiation Benzinga +5.08%
Aug-09-18 09:30AM  Is AcelRx Pharmaceuticals (ACRX) Outperforming Other Medical Stocks This Year? Zacks
Aug-08-18 07:00AM  AcelRx Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire +7.02%
Aug-02-18 06:20PM  AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Misses Revenue Estimates Zacks
05:15PM  AcelRx Pharmaceuticals: 2Q Earnings Snapshot Associated Press
04:01PM  AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  AcelRx Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-19-18 11:14AM  CTI BioPharma Tanks Post Type B Talks on Pacritinib With FDA Zacks
08:33AM  AcelRx to announce second quarter 2018 results and provide a corporate update on Thursday, August 2nd, 2018 PR Newswire
Jul-18-18 07:10AM  Free Technical Research on Medtronic and Three More Medical Equipment Equities ACCESSWIRE
Jul-13-18 01:56PM  Why You Shouldnt Get Too Excited About AcelRx Pharmaceuticals (ACRX) Stock SmarterAnalyst +8.47%
Jul-12-18 09:30AM  AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire -13.24%
08:37AM  Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial Benzinga
Jul-11-18 04:07PM  AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock PR Newswire
09:37AM  Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2 Zacks
09:14AM  VIVUS' PAH Candidate Data Positive in Early Stage Study Zacks
Jul-10-18 09:58AM  Aclaris' Alopecia Candidate Gets Fast Track Designation Zacks
Jul-02-18 09:04AM  Why this Peninsula drug company still is betting on pain for a gain American City Business Journals
Jun-27-18 07:00AM  AcelRx receives European Commission approval for DZUVEO PR Newswire
Jun-22-18 09:56AM  Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population Zacks
Jun-18-18 07:05AM  Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desks Radar ACCESSWIRE
Jun-15-18 11:28AM  Top Ranked Momentum Stocks to Buy for June 15th Zacks
Jun-12-18 12:19PM  Analyst: AcelRx Will Address FDA Concerns, Secure Approval This Year Benzinga
08:47AM  Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate Benzinga
08:15AM  Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-05-18 07:54AM  Top Ranked Momentum Stocks to Buy for June 5th Zacks
Jun-04-18 07:43AM  Top Ranked Momentum Stocks to Buy for June 4th Zacks
May-24-18 07:00AM  AcelRx announces FDA acceptance of NDA for DSUVIA PR Newswire +7.94%
May-23-18 07:00AM  Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures PR Newswire +8.62%
May-22-18 11:45AM  AcelRx Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference PR Newswire
May-18-18 10:37AM  Top Ranked Momentum Stocks to Buy for May 18th Zacks
May-17-18 07:23PM  Why You Need To Look At This Factor Before Buying AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Simply Wall St.
May-16-18 11:52AM  Edited Transcript of ACRX earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents +8.93%
May-11-18 07:10AM  Blog Exposure - AcelRx Pharma Resubmitted New Drug Application for DSUVIA with FDA ACCESSWIRE
May-09-18 05:28PM  AcelRx Pharmaceuticals: 1Q Earnings Snapshot Associated Press
04:05PM  AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results PR Newswire
12:27PM  Want To Invest In AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)? Heres How It Performed Lately Simply Wall St.
07:45AM  Stocks Under Scanner in the Medical Equipment Space Accuray and Two more Stock Research Monitor: ACRX, and CHFS ACCESSWIRE
07:00AM  AcelRx resubmits New Drug Application for DSUVIA PR Newswire
May-06-18 12:02PM  Best NasdaqGM Growth Companies Simply Wall St.
Apr-30-18 07:00AM  AcelRx Pharmaceuticals Reports Publication Analyzing Errors Associated with Existing IV Patient-Controlled Analgesia Systems PR Newswire
Apr-27-18 07:20AM  AcelRx receives positive CHMP opinion for DZUVEO for management of acute moderate to severe pain in medically monitored settings PR Newswire +6.52%
Apr-25-18 04:30PM  AcelRx to announce first quarter 2018 results and provide a corporate update on Wednesday, May 9th, 2018 PR Newswire
Apr-18-18 07:30AM  Blog Exposure - AcelRx Pharma Completes the Human Factors Study for DSUVIA ACCESSWIRE
07:00AM  AcelRx Pharmaceuticals Announces Publication Concluding that Sublingual Sufentanil Tablets Provide the Opportunity to Non-Invasively and Rapidly Treat Moderate-To-Severe Acute Pain in a Monitored Setting PR Newswire
Apr-16-18 07:00AM  AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018 PR Newswire +6.67%
Apr-11-18 09:15AM  AcelRx Announces Publication Analyzing the Cost of Administering IV Morphine for Acute Pain in Emergency Departments in Europe PR Newswire
Mar-27-18 07:00AM  AcelRx announces appointment of John Saia as General Counsel PR Newswire -6.38%
Mar-26-18 07:00AM  Blog Exposure - FDA Cleared Orthofix Internationals G-Beam Fusion Beaming System ACCESSWIRE +13.25%
Mar-20-18 06:06PM  When Can We Expect A Profit From AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)? Simply Wall St.
Mar-10-18 12:06AM  Edited Transcript of ACRX earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-18 08:10AM  Todays Research Reports on Stocks to Watch: AcelRx Pharmaceuticals and TherapeuticsMD ACCESSWIRE +10.53%
Mar-08-18 06:21PM  AcelRx Pharmaceuticals reports 4Q loss Associated Press +11.76%
04:06PM  AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results PR Newswire
04:01PM  AcelRx announces receipt of Type A FDA meeting minutes and plans to resubmit the DSUVIA New Drug Application in Q2 2018 PR Newswire
12:30PM  AcelRx Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 08:39AM  Are Options Traders Betting on a Big Move in AcelRx Pharmaceuticals (ACRX) Stock? Zacks
Mar-05-18 07:00AM  AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March PR Newswire
Mar-02-18 07:00AM  AcelRx Pharmaceuticals to Hold Annual 2017 Financial Results Conference Call and Webcast on Thursday, March 8th, 2018 PR Newswire
Feb-20-18 08:10AM  Research Report Identifies Pinnacle Financial Partners, Tribune Media, Ollie's Bargain Outlet, International Flavors & Fragrances, Harris, and AcelRx Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-16-18 07:00AM  AcelRx Pharmaceuticals to Present at 2018 RBC Capital Markets Global Healthcare Conference PR Newswire +8.57%
Jan-04-18 09:42AM  Omeros Inks Agreement With FDA for OMS721 Phase III Trial Zacks
Jan-03-18 03:42PM  Merck's Keytruda Gets Approved for Bladder Cancer in Japan Zacks
02:08PM  AcelRx Pharmaceuticals Incs (NASDAQ:ACRX) Earnings Declined -16.55%, But How Did It Fare Against The Industry? Simply Wall St.
08:16AM  AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q3, 2017 By the Numbers : January 3, 2018 Capital Cube
03:23AM  5 Reasons to Pick Emergent as an Investment-Worthy Stock Zacks
Dec-28-17 09:45AM  Actinium Posts Positive DMC View on Lomab-B Phase III Trial Zacks
Dec-08-17 07:50AM  Free Research Report as Masimos Revenue Jumped 15.6%; EPS Surged 35% ACCESSWIRE
Dec-04-17 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within International Flavors & Fragrances, Harris, AcelRx Pharmaceuticals, Pinnacle Financial Partners, Tribune Media, and Ollie's Bargain Outlet New Research Emphasizes Economic Growth GlobeNewswire
Nov-21-17 06:31PM  Edited Transcript of ACRX earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-16-17 07:00AM  AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain PR Newswire +7.89%
Nov-09-17 04:27PM  AcelRx Pharmaceuticals reports 3Q loss Associated Press
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dasu Badri NChief Engineering OfficerOct 15Sale5.0028,351141,75554,061Oct 16 04:29 PM
Hamel Lawrence GChief Development OfficerOct 15Sale5.005,21626,08029,795Oct 16 04:30 PM
Hamel Lawrence GChief Development OfficerSep 24Sale4.506,95331,28935,011Sep 26 05:54 PM
Angotti Vincent J.Chief Executive OfficerAug 07Buy2.9010,00028,95035,000Aug 07 04:08 PM
EDWARDS MARK GDirectorAug 07Buy2.845,30015,063160,300Aug 08 04:36 PM
Palmer Pamela PChief Medical OfficerAug 06Buy2.7537,000101,750456,134Aug 06 05:38 PM
ASADORIAN RAFFIChief Financial OfficerAug 06Buy2.755,00013,72532,000Aug 06 05:23 PM
EDWARDS MARK GDirectorJun 05Buy3.354,70015,745155,000Jun 05 05:52 PM
EDWARDS MARK GDirectorJun 01Buy3.30300990150,300Jun 05 05:52 PM
ASADORIAN RAFFIChief Financial OfficerMay 25Buy3.185,00015,92327,000May 29 06:52 AM
EDWARDS MARK GDirectorNov 14Buy1.9030,00056,970150,000Nov 15 07:01 AM
ASADORIAN RAFFIChief Financial OfficerNov 13Buy1.945,0009,71112,000Nov 14 07:01 AM